- Report
- March 2024
- 187 Pages
Global
From €3262EUR$3,374USD£2,784GBP
€3625EUR$3,749USD£3,093GBP
- Report
- April 2024
- 173 Pages
Global
From €4786EUR$4,950USD£4,084GBP
- Report
- April 2023
- 600 Pages
Global
From €5801EUR$6,000USD£4,950GBP
- Report
- October 2023
- 146 Pages
Global
From €3411EUR$3,528USD£2,910GBP
€4013EUR$4,150USD£3,424GBP
- Report
- February 2023
Global
From €3384EUR$3,500USD£2,887GBP
- Report
- October 2019
- 340 Pages
Global
From €4206EUR$4,350USD£3,589GBP
- Report
- July 2019
- 305 Pages
United States
From €2417EUR$2,500USD£2,062GBP
- Report
- July 2019
- 340 Pages
Global
From €4206EUR$4,350USD£3,589GBP
- Report
- July 2019
- 340 Pages
Global
From €4206EUR$4,350USD£3,589GBP
- Report
- June 2019
- 305 Pages
United States
From €2804EUR$2,900USD£2,392GBP
- Report
- May 2019
- 340 Pages
Global
From €4206EUR$4,350USD£3,589GBP
- Report
- April 2019
- 305 Pages
United States
From €2804EUR$2,900USD£2,392GBP
- Report
- December 2022
- 375 Pages
Global
From €5540EUR$5,730USD£4,727GBP
The Point-of-Care (POC) Lipid Test market is a segment of the larger Point-of-Care Diagnostics industry. It is composed of medical devices and tests used to measure the levels of lipids, such as cholesterol and triglycerides, in a patient's blood. These tests are typically used to diagnose and monitor cardiovascular diseases, and are often performed in a doctor's office or at home. POC Lipid Tests are typically more convenient and cost-effective than traditional laboratory tests, and can provide results in minutes.
The POC Lipid Test market is driven by the increasing prevalence of cardiovascular diseases, as well as the growing demand for convenient and cost-effective diagnostic solutions. The market is expected to continue to grow in the coming years, as more companies enter the space and develop innovative products.
Some of the major players in the POC Lipid Test market include Abbott, Roche, Siemens, Alere, and Biosite. Show Less Read more